SCHEMBL4583872

SCHEMBL4583872

CC(C)n1cc(-c2nc(C(N)=O)c(N)nc2-c2cccc(Cl)c2)ccc1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.44
ADORA2A P29274 6/20 0.43
ADORA1 P30542 2/20 0.43
PTPN11 Q06124 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.40
GAA P10253 1/20 0.38
CNR2 P34972 1/20 0.38
BMPR1B O00238 1/20 0.38
BMPR1A P36894 1/20 0.38
TGFBR1 P36897 1/20 0.38
ACVRL1 P37023 1/20 0.38
ACVR1 Q04771 1/20 0.38
ATR Q13535 3/20 0.38
PGR P06401 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
ESR1 P03372 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4584765 0.92 ADORA2A (0.43) ADORA2AADORA1PTGDR2BMPR1BBMPR1A
SCHEMBL4585807 0.89 ADORA2A (0.49) IKBKBADORA2AADORA1PTGDR2BMPR1B
SCHEMBL4584074 0.88 ADORA2A (0.50) ADORA2AADORA1PTGDR2BMPR1BBMPR1A
SCHEMBL4584782 0.87 ADORA2A (0.51) ADORA2AADORA1PTPN11PTGDR2BMPR1B
SCHEMBL4584451 0.85 IKBKB (0.47) IKBKBADORA2AADORA1RAB9ALMNA
SCHEMBL4584065 0.85 ADORA2A (0.50) ADORA2AADORA1PTGDR2BMPR1BBMPR1A
SCHEMBL4584131 0.84 ADORA2A (0.46) IKBKBADORA2AADORA1PTGDR2BMPR1B
SCHEMBL4585752 0.84 ADORA2A (0.43) IKBKBADORA2AADORA1PTGDR2CNR2
SCHEMBL4583849 0.84 ADORA2A (0.54) ADORA2AADORA1PTGDR2BMPR1BBMPR1A
SCHEMBL4584129 0.83 ADORA2A (0.46) IKBKBADORA2AADORA1BMPR1BBMPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407961-B2 Pyrazine derivatives and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2008-08-05 US disclosed
CN-1871231-A Pyrazine derivatives and pharmaceutical use thereof ASTELLAS PHARMA INC (JP) 2006-11-29 CN disclosed
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof ADORA2A, P2RX5, ADORA1 IKBKB 3409/4885ADORA2A 1/4885ADORA1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.